The Transcription Factor ZNF395 Is Required for the Maximal Hypoxic Induction of Proinflammatory Cytokines in U87-MG Cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Herwartz, Christine ^a   Castillo Juárez, Paola ^b   Schröder, Linda ^a   Barron, Blanca L ^b   Steger, Gertrud ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZNF395; UNCLASSIFIED DRUG; CYTOKINE; DNA BINDING PROTEIN; ZNF395 PROTEIN, HUMAN;

ARTICLE; ASTROCYTOMA CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; INFLAMMATION; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR GROWTH; U87 MG CELL; CELL HYPOXIA; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; CYTOKINES; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; TRANSCRIPTION FACTORS;

EID: 84937010751     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/804264     Document Type: Article

References (49)

1. H. K. Eltzschig and P. Carmeliet, "Hypoxia and inflammation," The New England Journal of Medicine, vol. 364, no. 7, pp. 656-665, 2011.
2. F. Colotta, P. Allavena, A. Sica, C. Garlanda, and A. Mantovani, "Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability," Carcinogenesis, vol. 30, no. 7, pp. 1073-1081, 2009.
3. W. R. Wilson and M. P. Hay, "Targeting hypoxia in cancer therapy," Nature Reviews Cancer, vol. 11, no. 6, pp. 393-410, 2011.
4. B. Westermark, "Glioblastoma-a moving target," Upsala Journal of Medical Sciences, vol. 117, no. 2, pp. 251-256, 2012.
5. V. F. Zhu, J. Yang, D. G. LeBrun, and M. Li, "Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis," Cancer Letters, vol. 316, no. 2, pp. 139-150, 2012.
6. Y. T. Yeung, K. L. McDonald, T. Grewal, and L. Munoz, "Interleukins in glioblastoma pathophysiology: implications for therapy," British Journal of Pharmacology, vol. 168, no. 3, pp. 591-606, 2013.
7. M. Tafani, M. Di Vito, A. Frati et al., "Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma," Journal of Neuroinflammation, vol. 8, article 32, 2011.
8. A. Murat, E. Migliavacca, S. F. Hussain et al., "Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia," PLoS ONE, vol. 4, no. 6, Article ID e5947, 2009.
9. A. Lal, H. Peters, B. St Croix et al., "Transcriptional response to hypoxia in human tumors," Journal of the National Cancer Institute, vol. 93, no. 17, pp. 1337-1343, 2001.
10. M. Olbryt, A. Habryka, S. Student et al., "Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia," PLoS ONE, vol. 9, no. 8, Article ID e105104, 2014.
11. T. Tsukahara, Y. Nabeta, S. Kawaguchi et al., "Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor," Cancer Research, vol. 64, no. 15, pp. 5442-5448, 2004.
12. H. Yabe, T. Tsukahara, S. Kawaguchi et al., "Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis," Oncology Reports, vol. 19, no. 1, pp. 129-134, 2008.
13. P. Fardin, A. Barla, S. Mosci et al., "A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients," Molecular Cancer, vol. 9, article 185, 2010.
14. G. S. Dalgin, D. T. Holloway, L. S. Liou, and C. DeLisi, "Identification and characterization of renal cell carcinoma gene markers," Cancer Informatics, vol. 3, pp. 65-92, 2007.
15. K. M. Skubitz, W. Zimmerman, R. Kammerer, S. Pambuccian, and A. P. N. Skubitz, "Differential gene expression identifies subgroups of renal cell carcinoma," Journal of Laboratory and Clinical Medicine, vol. 147, no. 5, pp. 250-267, 2006.
16. S. Couvé, C. Ladroue, E. Laine et al., "Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis," Cancer Research, vol. 74, no. 22, pp. 6554-6564, 2014.
17. F. Pang, R. Zha, Y. Zhao et al., "MiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395," PLoS ONE, vol. 9, no. 3, Article ID e90867, 2014.
18. H. Goodarzi, S. Zhang, C. G. Buss, L. Fish, S. Tavazoie, and S. F. Tavazoie, "Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins," Nature, vol. 513, no. 7517, pp. 256-260, 2014.
19. S. Boeckle, H. Pfister, and G. Steger, "A new cellular factor recognizes E2 binding sites of papillomaviruses which mediate transcriptional repression by E2," Virology, vol. 293, no. 1, pp. 103-117, 2002.
20. N. Sichtig, N. Körfer, and G. Steger, "Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex," Archives of Biochemistry and Biophysics, vol. 467, no. 1, pp. 67-75, 2007.
21. K. Tanaka, J. Shouguchi-Miyata, N. Miyamoto, and J.-E. Ikeda, "Novel nuclear shuttle proteins, HDBP1 and HDBP2, bind to neuronal cell-specific cis-regulatory element in the promoter for the human Huntington's disease gene," Journal of Biological Chemistry, vol. 279, no. 8, pp. 7275-7286, 2004.
22. D. Jordanovski, C. Koehler, and G. Steger, "ZNF395 (HDBP2/PBF) is a target gene of HIF1alpha," in Huntington's Disease-Core Concepts and Current Advances, InTech, 2012.
23. D. Jordanovski, C. Herwartz, A. Pawlowski, S. Taute, P. Frommolt, and G. Steger, "Thehypoxia-inducible transcription factor ZNF395 is controlled by IKB kinase-signaling and activates genes involved in the innate immune response and cancer," PLoS ONE, vol. 8, no. 9, Article ID e74911, 2013.
24. M. J. Clark, N. Homer, B. D. O'Connor et al., "U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line," PLoS Genetics, vol. 6, no. 1, Article IDe1000832, 2010.
25. K. J. Purdie, C. J. Sexton, C. M. Proby et al., "Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus," Cancer Research, vol. 53, no. 21, pp. 5328-5333, 1993.
26. C. Sundstrom and K. Nilsson, "Establishment and characterization of a human histiocytic lymphoma cell line (U-937)," International Journal of Cancer, vol. 17, no. 5, pp. 565-577, 1976.
27. M. W. Pfaffl, "A new mathematical model for relative quantification in real-time RT-PCR," Nucleic Acids Research, vol. 29, no. 9, article e45, 2001.
28. P. H. Maxwell, M. S. Wlesener, G.-W. Chang et al., "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis," Nature, vol. 399, no. 6733, pp. 271-275, 1999.
29. L. Franchi, R. Muñoz-Planillo, and G. Núñez, "Sensing and reacting to microbes through the inflammasomes," Nature Immunology, vol. 13, no. 4, pp. 325-332, 2012.
30. A. Kaidi, D. Qualtrough, A. C. Williams, and C. Paraskeva, "Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia," Cancer Research, vol. 66, no. 13, pp. 6683-6691, 2006.
31. G. M. Tannahill, A. M. Curtis, J. Adamik et al., "Succinate is an inflammatory signal that induces IL-1β through HIF-1α," Nature, vol. 496, no. 7444, pp. 238-242, 2013.
32. D. J. Brat, A. C. Bellail, and E. G. van Meir, "The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis," Neuro-Oncology, vol. 7, no. 2, pp. 122-133, 2005.
33. O. Safronova, K. Nakahama, M. Onodera, T. Muneta, and I. Morita, "Effect of hypoxia on monocyte chemotactic protein- 1 (MCP-1) gene expression induced by Interleukin-1beta in human synovial fibroblasts," Inflammation Research, vol. 52, no. 11, pp. 480-486, 2003.
34. O. S. Safronova, K. Nakahama, and I. Morita, "Acute hypoxia affects P-TEFb through HDAC3 and HEXIM1-dependent mechanism to promote gene-specific transcriptional repression," Nucleic Acids Research, vol. 42, no. 14, pp. 8954-8969, 2014.
35. J. Schödel, S. Oikonomopoulos, J. Ragoussis, C. W. Pugh, P. J. Ratcliffe, and D. R. Mole, "High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq," Blood, vol. 117, no. 23, pp. e207-e217, 2011.
36. G. P. Elvidge, L. Glenny, R. J. Appelhoff, P. J. Ratcliffe, J. Ragoussis, and J. M. Gleadle, "Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1α, HIF-2α, and other pathways," The Journal of Biological Chemistry, vol. 281, no. 22, pp. 15215-15226, 2006.
37. B. Raychaudhuri and M. A. Vogelbaum, "IL-8 is a mediator of NF-κB induced invasion by gliomas," Journal of Neuro-Oncology, vol. 101, no. 2, pp. 227-235, 2011.
38. H. Wang, J. D. Lathia, Q. Wu et al., "Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth," Stem Cells, vol. 27, no. 10, pp. 2393-2404, 2009.
39. G. Germano, P. Allavena, and A. Mantovani, "Cytokines as a key component of cancer-related inflammation," Cytokine, vol. 43, no. 3, pp. 374-379, 2008.
40. T. Atsumi, R. Singh, L. Sabharwal et al., "Inflammation amplifier, a new paradigm in cancer biology," Cancer Research, vol. 74, no. 1, pp. 8-14, 2014.
41. L. Wu, H. Yu, Y. Zhao et al., "HIF-2alpha mediates hypoxiainduced LIF expression in human colorectal cancer cells," Oncotarget, vol. 6, no. 6, pp. 4406-4417, 2015.
42. S. Peñuelas, J. Anido, R. M. Prieto-Sánchez et al., "TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma," Cancer Cell, vol. 15, no. 4, pp. 315-327, 2009.
43. J. Skog, T. Würdinger, S. van Rijn et al., "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers," Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
44. P. Kucharzewska, H. C. Christianson, J. E. Welch et al., "Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 18, pp. 7312-7317, 2013.
45. V. R. Martins, M. S. Dias, and P. Hainaut, "Tumor-cell-derived microvesicles as carriers of molecular information in cancer," Current Opinion in Oncology, vol. 25, no. 1, pp. 66-75, 2013.
46. K. Geiger, A. Leiherer, A. Muendlein et al., "Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis," PLoS ONE, vol. 6, no. 10, Article ID e26465, 2011.
47. E. P. Cummins, E. Berra, K. M. Comerford et al., "Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 48, pp. 18154-18159, 2006.
48. J. Rius, M. Guma, C. Schachtrup et al., "NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α," Nature, vol. 453, no. 7196, pp. 807-811, 2008.
49. 2 availability on human cancer," Nature Reviews Cancer, vol. 8, no. 12, pp. 967-975, 2008.